Kura Oncology, Inc. (KURA) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US50127T1097
Kura Oncology, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 67.48 m USD |
| Operating income | -303.63 m USD |
| EBIT | -276.86 m USD |
| Net income | -278.67 m USD |
| Diluted EPS – continuing operations | -3.18 USD |
Full history since 2008, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Kura Oncology, Inc.
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
More stocks
- Newonder Special Electric Co.Ltd (301120.SZ)
- Shanghai Zhongzhou Special Alloy Materials Co. Ltd. (300963.SZ)
- Third Coast Bancshares, Inc. (TCBX)
- Ubisoft Entertainment SA (UBI.PA)
- Atal SA (1AT.WA)
- J.S. Corrugating Machinery Co Ltd (000821.SZ)
- Shandong Huatai Paper Industry Shareholding Co Ltd (600308.SS)
- Shandong Keyuan Pharmaceutical Co. Ltd. A (301281.SZ)
- Metro Healthcare Indonesia (CARE.JK)
- Melco International Development Ltd (200.HK)
- Smartone Telecommunications Holdings Ltd (315.HK)
- Jiangsu SINOJIT Wind Energy Technology Co Ltd (601218.SS)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.